ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

Articles By Krithiga Narayanan

Drug Price Control in India

Price control of life-saving essential medicines is the need of the hour, but the National Pharmaceutical Pricing Authority has allowed a hike of 10% in nearly 800 drugs and devices listed under the National List of Essential Medicines from 1 April 2022 because of the rising input costs. Prices of scheduled drugs are allowed an increase each year acc­ording to the wholesale price index. Input costs are rising primarily because India is heavily dependent on China for drug imports.